Healthcare - Medical - Devices - NASDAQ - US
$ 1.19
-7.75 %
$ 2.5 M
Market Cap
-0.06
P/E
CASH FLOW STATEMENT
-9.56 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
5.04 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Bone Biologics Corporation
| Net Income | -8.95 M |
| Depreciation & Amortization | 9.43 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 153 K |
| Change in Working Capital | 133 K |
| Others | -1.02 M |
| Free Cash Flow | -9.56 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Oct-2013 | Oct-2012 | Oct-2011 | Oct-2010 | Oct-2009 | Oct-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | (8.9) | (1.5) | (1.6) | (1.8) | (3.4) | (4.4) | (7.1) | (21.0) | (13.9) | (4.4) | (1.1) | 716 | 3.6 K | 49 K | 10.3 K | 13.3 K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 50 | 96 | 96 | 700 | 4.45 K | 280 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (0.3) | (0.7) | 0 | 6.1 | 0.5 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.3 | 0.2 | 60 K | 49.7 K | 0.5 | (0.6) | 3.5 | 3.7 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | (0.9) | (2.2) | 0.5 | 0.9 | 0.3 | 0.4 | 3.4 | 4.0 | 6.0 | 1.4 | 0.5 | 268 | 2.08 K | 3.6 K | 5.41 K | 11 K |
| Change in Working Capital | 0.1 | (0.2) | (0.3) | 0.4 | 0.1 | 0.1 | 0.9 | 0.1 | 88 K | (0.9) | 35.2 K | 0 | 0 | 0 | 0 | 0 |
| Cash From Operations | (9.6) | (3.6) | (1.2) | (0.4) | (3.3) | (4.1) | (3.3) | (7.3) | (3.5) | (2.8) | (0.5) | 447 | 5.68 K | 45.5 K | 4.87 K | 24.3 K |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 504 | 11.9 K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.4 K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 504 | 25.5 K | 0 | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 1.0 | 0.4 | 2.3 | 0 | 2.7 | 3.1 | 2.0 | 4.9 | 0.5 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 0 | 0 | 0 | 449 | 5.68 K | 45.5 K | 1.8 K | 15.3 K |
| Cash From Financing Activities | 5.0 | 4.4 | 7.9 | 0.4 | 2.3 | 4.4 | 3.4 | 6.8 | 2.0 | 5.4 | 0.5 | 449 | 5.68 K | 45.5 K | 1.8 K | 15.3 K |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | (4.5) | 0.9 | 6.7 | 24.1 K | (0.9) | 0.3 | 69.9 K | (0.5) | (1.5) | 2.7 | 1.04 K | 1.12 | 0 | 0 | 3.08 K | 9.02 K |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | (9.6) | (3.6) | (1.2) | (0.4) | (3.3) | (4.1) | (3.3) | (7.3) | (3.5) | (2.8) | (0.5) | 447 | 5.68 K | 45.5 K | 4.87 K | 24.3 K |